William D Clark's Net Worth
$4.02 Million
Who is William D Clark?
William D Clark has an estimated net worth of $4.02 Million. This is based on reported shares across multiple companies, which include Vanda Pharmaceuticals Inc., GENOCEA BIOSCIENCES, INC., iBio, Inc., and Arsanis, Inc..
SEC CIK
William D Clark's CIK is 0001355415
Past Insider Trading and Trends
2009 was William D Clark's most active year for acquiring shares with 9 total transactions. William D Clark's most active month to acquire stocks was the month of November. 2007 was William D Clark's most active year for disposing of shares, totalling 42 transactions. William D Clark's most active month to dispose stocks was the month of October. 2014 saw William D Clark paying a total of $113,848.02 for 121,477 shares, this is the most they've acquired in one year. In 2009 William D Clark cashed out on 538,299 shares for a total of $2,406,431.30, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vanda Pharmaceuticals Inc. (VNDA) Snapshot price: $3.625
Sr. VP, Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.36% | -9.52K |
$10.65 | -$101,409.30 | 168.28K |
Feb 19
| |||
Form 4
| +16.36% | 25K |
—
|
—
| 177.8K |
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
| +103.73% | 77.8K |
$5.69 | -$2,308,604.25 | 152.8K |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +50.00% | 25K |
—
|
—
| 75K |
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
| +100.00% | 50K |
—
|
—
| 100K |
Dec 16
| |||
Form 4
|
∞
| 50K |
$0.99 | $49,500.00 | 50K |
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
$7.10 | -$43,324.80 |
0
|
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$9.58 | -$59,222.90 |
0
|
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$10.22 | -$63,288.80 |
0
|
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
$12.23 | -$76,156.80 |
0
|
Scheduled
|
Apr 2
| ||
Form 4
|
—
|
0
|
$14.93 | -$93,394.08 |
0
|
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
$13.31 | -$389,215.50 |
0
|
Dec 11
| |||
Form 4
| -100.00% | -6.30K |
$11.55 | -$72,792.00 |
0
|
Nov 8
| |||
Form 4
|
∞
| 6.3K |
$5.74 | -$135,318.98 | 6.3K |
Nov 7 - Nov 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GENOCEA BIOSCIENCES, INC. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.30% | -4.02K |
$0.06 | -$241.38 | 304.38K |
Jun 2
| |||
Form 4
| -27.55% | -117.24K |
$0.06 | -$7,233.95 | 308.4K |
May 31
| |||
Form 4
| -1.05% | -3.92K |
$1.25 | -$4,905.00 | 369.49K |
Apr 4
| |||
Form 4
| +59.00% | 138.56K |
$1.10 | -$12,578.50 | 373.41K |
Mar 15 - Mar 16
| |||
Form 4
|
∞
| 150K |
—
|
—
| 150K |
Mar 15
| |||
Form 4
| +133.93% | 36.5K |
$2.24 | $81,784.56 | 63.75K |
Feb 17
| |||
Form 4
|
∞
| 4.76K |
$2.06 | $9,805.60 | 4.76K |
Nov 10
| |||
Form 4
|
∞
| 27.34K |
—
|
—
| 27.34K |
Jun 1
| |||
Form 4
|
∞
| 50.78K |
—
|
—
| 50.78K |
Apr 2
| |||
Form 4
| +14.30% | 15K |
$0.54 | $8,100.00 | 119.93K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
| +43.15% | 25K |
$0.80 | $20,000.00 | 82.93K |
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
| +5.67% | 2.8K |
$3.49 | $9,772.00 | 52.2K |
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
| +9.55% | 3.8K |
$6.45 | $24,510.00 | 43.61K |
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
| +99.04% | 19.81K |
$2.86 | $56,648.02 | 39.81K |
Dec 12
| |||
Form 4
|
∞
| 20K |
$2.86 | $57,200.00 | 20K |
Sep 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
iBio, Inc. (IBIO) Snapshot price: $1.0985
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arsanis, Inc. (XFOR) Snapshot price: $0.8557
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||